Researchers say they have stumbled upon a new technique that can reasonably predict which male getting treated for ??prostate cancer is at a higher risk of suffering from impotency. Cancer is a condition that can be fatal and hence the most important thing to do in this case is to prolong survival. But in the early stages of this cancer, it is unlikely that men will ??survive. After the treatment, the next thing that the medicos have to survive is the side effects of each treatment that goes into giving the patient a new life. How is the test done?
In most cases, the study involves assessing the sexual function pre-treatment; lifestyle of the patient along with including the tool can distinguish between the freshly diagnosed cases of erectile dysfunction known as clinical markers. Some specific diagnostic tests PSA blood test also known as prostate-specific antigen test may indicate tumors of the prostate. However, the treatments involved come with special side effects. For the treatment of prostate cancer, often including erectile dysfunction (ED), irregular and frequent urination, dysfunction of the bowels etc.
Study
A group of scientists and researchers did a study that involved distributing questionnaires to over 1,200 new diagnoses of prostate cancer .The surveys indicates the age of the patient, the severity of prostate cancer, PSA levels, BMI, race and ethnicity, level of sexual activity, and a history of erectile dysfunction or its treatment. All there patients underwent various forms of treatments and therapies and were followed for two years.
Result
As per the researchers, the risk of male erectile dysfunction treatment varies. For example, 60 % of men without erectile dysfunction problems before undergoing treatment for prostrate, complained of this sexual dysfunction within 2 years. 40 % of men who never complained of erectile dysfunction had a problem after they went through external radiations. Similarly less than 40 % of men who underwent brachytherapy complained of this problem. Subsequent analysis of survey responses revealed a link between high levels of PSA and increased risk of erectile dysfunction.
In most cases, the study involves assessing the sexual function pre-treatment; lifestyle of the patient along with including the tool can distinguish between the freshly diagnosed cases of erectile dysfunction known as clinical markers. Some specific diagnostic tests PSA blood test also known as prostate-specific antigen test may indicate tumors of the prostate. However, the treatments involved come with special side effects. For the treatment of prostate cancer, often including erectile dysfunction (ED), irregular and frequent urination, dysfunction of the bowels etc.
Study
A group of scientists and researchers did a study that involved distributing questionnaires to over 1,200 new diagnoses of prostate cancer .The surveys indicates the age of the patient, the severity of prostate cancer, PSA levels, BMI, race and ethnicity, level of sexual activity, and a history of erectile dysfunction or its treatment. All there patients underwent various forms of treatments and therapies and were followed for two years.
Result
As per the researchers, the risk of male erectile dysfunction treatment varies. For example, 60 % of men without erectile dysfunction problems before undergoing treatment for prostrate, complained of this sexual dysfunction within 2 years. 40 % of men who never complained of erectile dysfunction had a problem after they went through external radiations. Similarly less than 40 % of men who underwent brachytherapy complained of this problem. Subsequent analysis of survey responses revealed a link between high levels of PSA and increased risk of erectile dysfunction.